Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Change in Cash (2023 - 2024)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Change in Cash of -$8.43 million in Q4 2025, compared with $25.71 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Change in Cash (2023 - 2024) Analysis & Trends

For FY2025, Eupraxia Pharmaceuticals reported Change in Cash of $46.92 million, up 198.6% from FY2024.

  • Annual Change in Cash has a three-year compound annual growth rate of 95.9% (FY2022 to FY2025).
  • Across earlier years, Change in Cash came in at $15.71 million in FY2024, $256,970 in FY2023 (-95.9%) and $6.24 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.51 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.76 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.04 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 845.00 Mn
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 25.71 Mn
Sep 30, 2024 -14.83 Mn
Dec 31, 2023 -6.01 Mn
Sep 30, 2023 10.33 Mn
API Access

Eupraxia Pharmaceuticals Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=EPRX&period=max&api_key=YOUR_API_KEY